Basic Information
| LncRNA/CircRNA Name | circ_0000729 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Lung Adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, other |
| Sample | LUAD tissues |
| Expression Pattern | up-regulated |
| Function Description | We built a network of hsa_circ_0000792-targeted miRNA gene interactions, including miR-375 and the corresponding messenger RNAs. Gene Ontology analysis revealed that hsa_circ_0000792 could participate in signal transduction and cell communication during LUAD development. Larger area under the curve by receiver operating characteristic curve analysis of hsa_circ_0000792 and miR-375 (0.815 and 0.772, respectively) in LUAD indicated greater potential as biomarkers. |
| Pubmed ID | 29932500 |
| Year | 2018 |
| Title | hsa_circ_0000729, a Potential Prognostic Biomarker in Lung Adenocarcinoma |
External Links
| Links for circ_0000729 | GenBank HGNC NONCODE |
| Links for Lung Adenocarcinoma | OMIM COSMIC |